Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography
about
Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelAntithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulationRapid ungated myocardial perfusion cardiovascular magnetic resonance: preliminary diagnostic accuracy.Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease.The prognostic effects of ventricular heart rate among patients with permanent atrial fibrillation with and without coronary artery disease: a multicenter prospective observational studyRelationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan.The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulantsComparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.Individualising Anticoagulant Therapy in Atrial Fibrillation PatientsElectrophysiology and heart rhythm disorders in older adults.Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study.Is SYNTAX Score Predictive of Atrial Fibrillation after On-Pump Coronary Artery Bypass Graft Surgery?Advantages of a workbench reshaped AR1 mod catheter for right coronary angiography by right radial approach.Management of atrial fibrillation in patients undergoing percutaneous coronary intervention.Dual antiplatelet therapy in the anticoagulated patient undergoing percutaneous coronary intervention risks, benefits, and unanswered questions.Antiplatelet Therapy During PCI for Patients with Stable Angina and Atrial Fibrillation.Drug-drug interactions of non-vitamin K oral anticoagulants.Use of rivaroxaban in patients with stroke.Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions.Effect of Atrial Fibrillation on Contrast-Induced Nephropathy Development in Patients With Non-ST-Segment Elevation Myocardial Infarction.Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis.Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention.Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
P2860
Q26741058-300BFE38-4DA9-485E-BD06-262C0E4684EEQ28072522-637A43E5-0A74-4A4D-97E1-D32DCC840452Q30542915-3F0B8785-2E46-4159-93AE-510A81FBB757Q35670766-C1042F51-8FD8-4E40-AD6D-17A8360970E5Q36193666-AFE299A8-0649-4E0B-8EFA-5D71492D7E0CQ36353087-1A72BDF5-2B25-4961-B677-0802773FC31DQ36396649-F3C023A2-7D5F-450C-A99D-DE92E0E13502Q36587229-FEE18F57-2993-48BA-A294-857B0859ED1FQ36713982-710020CF-DA71-4701-8782-FE7EDF76F913Q37235927-C35F6457-D9B9-406C-BCFA-59D2DF7D59E8Q37345208-FE52C705-73F9-4AE4-98F4-AB8D5F4718EEQ37345221-7A5BC822-97AE-42D9-92B8-7665C9442B03Q37399220-27CB0DAC-5578-4B12-98BA-34EF4CCEA40BQ37640200-1A9B50A2-D63C-4571-A5E9-AEA426318AAAQ38210217-27F1C93F-CB6E-437D-A6A9-9CF54465C19FQ38261199-78AFD464-ACBF-4616-9703-7EE3FCC61DC6Q38535999-CD77B34E-2C3C-4EA6-98A0-B6F2B3D9CBF1Q38830358-C9E3C822-A612-4BEC-88A9-139AF718E0DBQ38941684-A8D6018C-0823-459F-8831-CB3158659A77Q39295736-77A11A35-6C61-4521-B09D-A96654B9FB67Q41104424-8A88DAC9-E95D-414B-958C-D7A859C0D1F8Q42360039-B012B611-6B74-4F7C-AD8C-520CE52A4686Q49687479-F6C2FA15-0E72-4E69-83CC-44E83B455245Q49876490-3B758446-6326-4867-8D74-62A24F60297EQ54975902-F4E4BD68-E284-4446-821C-B604BC94421DQ55105393-F3A86468-AFE4-4160-9F13-F73701895A8DQ55113397-4198A9A3-9864-4A69-B7EE-B5DC2B9B3CB5
P2860
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Incidence and severity of coro ...... irst-time coronary angiography
@ast
Incidence and severity of coro ...... irst-time coronary angiography
@en
Incidence and severity of coro ...... irst-time coronary angiography
@nl
type
label
Incidence and severity of coro ...... irst-time coronary angiography
@ast
Incidence and severity of coro ...... irst-time coronary angiography
@en
Incidence and severity of coro ...... irst-time coronary angiography
@nl
prefLabel
Incidence and severity of coro ...... irst-time coronary angiography
@ast
Incidence and severity of coro ...... irst-time coronary angiography
@en
Incidence and severity of coro ...... irst-time coronary angiography
@nl
P2093
P2860
P1433
P1476
Incidence and severity of coro ...... irst-time coronary angiography
@en
P2093
Kathrin Schneider
Stefan Kralev
Tim Süselbeck
P2860
P304
P356
10.1371/JOURNAL.PONE.0024964
P407
P577
2011-09-21T00:00:00Z